Staging of liver fibrosis or cirrhosis: The role of hepatic venous pressure gradient measurement
Open Access
- 1 January 2015
- journal article
- review article
- Published by Baishideng Publishing Group Inc. in World Journal of Hepatology
- Vol. 7 (3), 607-615
- https://doi.org/10.4254/wjh.v7.i3.607
Abstract
Liver fibrosis is a common histological change of chronic liver injury and it is closely related with portal hypertension which is hemodynamic complication of chronic liver disease. Currently, liver fibrosis has been known as a reversible dynamic process in previous literatures. Although liver biopsy is a gold standard for assessing the stage of liver fibrosis, it may not completely represent the stage of liver fibrosis because of sampling error or semi-quantative measurement. Recent evidences suggested that histologic, clinical, hemodynamic, and biologic features are closely associated in patients with chronic liver disease. Hepatic venous pressure gradient (HVPG) measurement has been known as a modality to evaluate the portal pressure. The HVPG measurement has been used clinically for fibrosis diagnosis, risk stratification, preoperative screening for liver resection, monitoring the efficacy of medical treatments, and assessing the prognosis of liver fibrosis. Therefore, the HVPG measurement can be used to monitor areas the chronic liver disease but also other important areas of chronic liver disease.Keywords
This publication has 99 references indexed in Scilit:
- Relationship between the hepatic venous pressure gradient and first variceal hemorrhage in patients with cirrhosis: a multicenter retrospective study in KoreaClinical and Molecular Hepatology, 2012
- Noninvasive Tools to Assess Hepatic Fibrosis: Ready for Prime Time?Gastroenterology Clinics of North America, 2011
- Now there are many (stages) where before there was one: In search of a pathophysiological classification of cirrhosisHepatology, 2009
- Diagnosis and Quantitation of FibrosisGastroenterology, 2008
- Mechanisms of Hepatic FibrogenesisGastroenterology, 2008
- Liver cirrhosisThe Lancet, 2008
- Common and unique mechanisms regulate fibrosis in various fibroproliferative diseasesJCI Insight, 2007
- Matrix metalloproteinases, the pros and cons, in liver fibrosisJournal of Gastroenterology and Hepatology, 2006
- Increased ADAMTS‐13 proteolytic activity in rat hepatic stellate cells upon activation in vitro and in vivoJournal of Thrombosis and Haemostasis, 2006
- Sampling variability of liver fibrosis in chronic hepatitis CHepatology, 2003